Laboratory services supplier Bellen Chemistry has followed a Legend Capital-backed round last year by raising a nine-figure renminbi sum.
Bellen Chemistry, a China-based laboratory services provider backed by conglomerate Legend Holdings, has received a nine-figure renminbi (RMB100m = $14.6m) amount of series C financing, ChinaBio Today has reported.
The round was co-led by venture capital firm Apricot Capital, financial services firm China Merchants Bank and Qianhai Fund of Funds, the investment vehicle closed at $3.3bn in early 2016.
Founded in 2007, Bellen designs and develops molecules for use by clients in the pharmaceutical and chemical industries. It also creates…
